While CSF Aβ42 is consistently reduced in PD patients with cognitive impairment or dementia, levels of total and phosphorylated tau generally remain within normal ranges and do not reliably differentiate PD dementia from non-demented Parkinson’s disease [110]. This evidence concerns the gene MAPT and dementia.